×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.09 | 84.8 |
| Triochem Products Ltd., | 2.95 | -1.93 | NA | -7.86 | 0 | |
| ALIVUS LIFE SCIENCES LIMITED | 6,027.00 | 1,300.26 | 5,879.80 | 10.58 | 11,522 | 23.2 |
| Blue Jet Healthcare Limited | 1,897.52 | 521.36 | 1,654.81 | 3.01 | 11204 | 31.2 |
| ACUTAAS CHEMICALS LIMITED | 3141.63 | 728.92 | 3051.93 | 8.9 | 11119 | 58.8 |
Glenmark Life Sciences Limited, with Security Code 543322, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 536.6 | 588.6 | 506.9 | 641.8 | 649.5 | 601.8 | 588.0 | 588.0 |
| Expenses | 395.2 | 429.1 | 372.5 | 451.5 | 451.1 | 429.5 | 408.8 | 408.8 |
| Operating Profit | 141.4 | 159.5 | 134.4 | 190.3 | 198.5 | 172.3 | 179.2 | 179.2 |
| OPM % | 26.36% | 27.09% | 26.51% | 29.65% | 30.56% | 28.63% | 30.47% | 30.47% |
| Other Income | 3.1 | 5.5 | 8.5 | 10.5 | 10.1 | 9.0 | 14.7 | 14.7 |
| Interest | 0.4 | 0.4 | 0.3 | 0.5 | 1.3 | 1.3 | 1.3 | 1.3 |
| Depreciation | 14.5 | 14.4 | 15.1 | 15.2 | 16.0 | 17.1 | 18.4 | 18.4 |
| Profit before tax | 129.7 | 150.2 | 127.5 | 185.1 | 191.3 | 163.0 | 174.1 | 174.1 |
| Tax % | -24.5% | 25.8% | 25.2% | 26% | -25.8% | 25.4% | 25.3% | -25.3% |
| Net Profit | 97.9 | 111.5 | 95.3 | 137.0 | 141.9 | 121.5 | 130.0 | 130.0 |
| EPS in Rs | 7.97 | 9.08 | 7.75 | 11.14 | 0 | 9.88 | 10.58 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 4% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 9% |
| 3 Years: | 5% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 37% |
| 1 Year: | 34% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 12% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 37% |
| 1 Year: | 34% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|